Trial
NCT00346229
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
filgrastim
Why stopped
Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-22